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Abstract 
 
The utilization of multiple phosphorylation sites in regulating a biological response is 
ubiquitous in cell signaling.  If each site contributes an additional, equivalent binding site, 
then one consequence of an increase in the number of phosphorylations may be to 
increase the probability that, upon disassociation, a ligand immediately rebinds to its 
receptor.  How such effects may influence cell signaling systems has been less studied.  
Here, a self-consistent integral equation formalism for ligand rebinding, in conjunction 
with Monte Carlo simulations, is employed to further investigate the effects of multiple, 
equivalent binding sites on shaping biological responses.  Multiple regimes that 
characterize qualitatively different physics due to the differential prevalence of rebinding 
effects are predicted.  Calculations suggest that when ligand rebinding contributes 
significantly to the dose response, a purely allovalent model can influence the binding 
curves nonlinearly.  The model also predicts that ligand rebinding in itself appears 
insufficient to generative a highly cooperative biological response.   
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 INTRODUCTION 
 The establishment of precise controls within signaling modules is an evolutionary 
prerequisite for a robustly functioning cellular system.  A central issue to such control is 
the regulation of a dose response or the necessary input-output relationships that direct a 
specific biological function1,2.  One such input that is widely utilized in many biological 
systems is the number of phosphorylations on a protein containing many potential 
phosphorylation sites.  Multisite phosphorylation is ubiquitous in cell biology and 
regulates myriad cell decisions3-5.   
 One salient example comes from the regulation of the cell cycle by ubiquitin 
mediated protein degradation, a key motif in the control of the cell cycle5,6.  In the 
seminal work by Nash et al.7 , the authors show that the CDK inhibitor, Sic1 functions 
through a thresholding mechanism – Sic1 must be phosphorylated at least 6 six (of its 9 
possible) sites in order to be ubiquitinated and subsequently targeted for degradation.  
Sic1 is intrinsically disordered8 and the location and specificity of these six 
phosphorylation sites seems to be unimportant at least to some extent.  This observation 
among others9 led to the hypothesis that the function of these seemingly redundant post 
translational modifications may be to increase the probability that Sic1 rebinds to its 
substrate upon disassociation10,11 and a mathematical model10 was developed to 
investigate the rebinding of a polyvalent ligand.  In this model, a ligand, once 
disassociated, effectively escapes from its receptor unless it is phosphorylated a sufficient 
number of times so as to increase its chances of rebinding.      
 The problem of ligand rebinding has been extensively studied in many contexts12-
17.  Some of the most comprehensive studies were carried out in the context of two 
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settings: 1.) ligand binding/unbinding to and from a surface as a model for the kinetics of 
ligand binding to cell-surface receptors13,15,18 and 2.) chemotaxis and autocrine signaling 
resulting in rebinding of a ligand secreted from a cell12,19,20.  In each of these studies, it 
was demonstrated that ligand rebinding can be very significant.  Despite these advances, 
how changes in the phosphorylation state of a substrate is related to rebinding and how 
this affects a biological dose response curve has not been fully investigated.  A schematic 
of this effect is shown in Fig. 1.    
 Towards this end, we use an integral equation theory and Monte Carlo 
simulations to study the rebinding of a ligand to a receptor from which it initially 
disassociated and how this rebinding may be affected by multiple recognition sites.  From 
considering only the effects of a single molecule rebinding to its receptor, we compute 
the time dependence of the probability that a ligand remains bound as a function of the 
number of phosphorylations.  In turn, we compute the probability that a ligand escapes its 
target as function of the number of recognition sites.  The model and numerical 
simulations predict that this escape probability can decrease nearly exponentially as a 
function of the number of independent binding sites thus suggesting that ligand rebinding 
greatly affects the binding kinetics.  We also highlight the importance of two physical 
regimes of ligand rebinding that are characterized by weak and strong rebinding and 
show how each regime may affect the input-output relationships of a system with 
multiple phosphorylation sites.  We further note that the model predicts that, although a 
ligand’s propensity to immediately rebind, as a function of the number of available 
binding sites, greatly affects the shape of the biological response, additional mechanistic 
ingredients appear to be required to achieve a highly cooperative response.  Finally, we 
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note that while our model predicts that the probability of a polyvalent ligand escaping 
from its receptor decreases exponentially as a function of the number of binding sites, 
this property appears insufficient to give rise to a highly cooperative response as has been 
previous predicted10.  The source of this discrepancy appears to lie in how the rate 
constants in the previous phenomenological model were varied independently to achieve 
the desired cooperativity.   
METHODS AND MODEL DEVELOPMENT 
Multisite phosphorylation and ligand rebinding 
 The key considerations that are used to develop our model lie in the questions that 
we wish to address in this study.  In particular, our aim is to investigate how ligand 
rebinding may be affected by multisite phosphorylation.  Other studies of multisite 
phosphorylation have investigated the consequences of other physical effects such as 
distributive phosphorylation and feedback regulation4,21.  We are interested in computing 
the probability that a ligand remains bound as a function of time and as a function of the 
number of recognition sites on the receptor.   
 To model this scenario, we assume that at time zero, a ligand is bound to its 
receptor and can be released with a constant unit time probability.  When the ligand is in 
immediate proximity of the receptor, there is a probabilityθ  that the ligand rebinds to the 
receptor within the time it takes to diffuse away from the immediate vicinity of the 
recognition domain.  Multiple phosphorylations are then parameterized by a change in 
this probability.  In the case we consider, which we refer to as the ‘allovalent’ model10, 
each phosphorylation contributes equally and independently to the value of the 
parameterθ ; i.e.  
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     0nθ θ= ,  
where n  is the number of phosphorylations and 0θ is the probability that a ligand that is 
proximally located to the recognition site will rebind when it is singly phosphorylated on 
any site.  In the work by Klein et al10, this assumption (that each site contributes equally 
and independently to the rebinding probability) was sufficient to give rise to a highly 
cooperative response.  Our aim is to further investigate the consequences of such an 
assumption.   
 Important to note is that in order for θ  to be a probability it must be less than or 
equal to one.  Therefore, 0θ  must be bounded by N
1 ;  
     
N
1
0 ≤θ ,  
where N is the maximum number of phosphorylation sites on the ligand.  An additional 
complication that is not considered here is the time dependence of n that may become 
important at late times.  The theory therefore aims to investigate solely how rebinding is 
affected given a fixed number of binding sites.  Also, this description of ligand binding is 
considered to be a “mean field” treatment since all conformational fluctuations of both 
the ligand and its receptor are neglected by the introduction of the parameter θ .  One 
could also imagine that θ could have a complex, nonlinear dependence on n for a given 
0θ  (i.e. ( )0;f nθ θ= ) as would be the case when cooperative electrostatic interactions 
among the multiple phosphate groups influence binding22. 
A self-consistent integral equation theory for ligand rebinding 
 To begin our analysis, we exploit a formalism that monitors the trajectories of a 
single ligand as it disassociates from and potentially rebinds to its target to which it was 
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originally bound.  The formalism was developed by Tauber et al.15 who investigated the 
effects of a ligand binding to a collection of receptors on a planar surface in the context 
of surface plasmon resonance studies.  Although our approach is similar in many regards, 
there are some subtleties that distinguish the two approaches and they are discussed 
within our treatment.  We consider an equation that describes the time-evolution of the 
probability, ( )f t , for a single ligand to be bound to its receptor provided that it is initially 
bound to its target.  The initial condition ( )0 1f = is used.  Single molecule master 
equations of this sort have been used extensively in many different contexts23.     
 A knowledge of this function allows one to compute the probability that a ligand 
is bound as a function of time as well a time dependent escape probability which is taken 
to be, ( )1 f t− .  A differential equation for the time evolution of ( )f t can be written as    
 df
dt
υ υ+ −= −  (1) 
The negative contributionυ−  simply follows first order disassociation kinetics (i.e. 
( )k f tυ− −= ). Thus, in the absence of rebinding ( 0υ+ = ), ( )f t decays via a single 
exponential with time constant 1
k−
, ( ) k tf t e −−= .  υ+  on the other hand is entirely due to 
the contribution from the rebinding of a single previously disassociated ligand.  The 
forward rate of binding, υ+ , is therefore the probability that a protein dissociates in the 
interval τ and dτ τ+  and then subsequently rebinds at a later time interval, t τ−  and 
( )t dτ τ− + , integrated over all previous times,τ .  An equation for υ+ , therefore, can be 
written as follows: 
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            ( ) ( )
0
,
t
k d f R tυ τ τ δ τ+ −= −∫ .         (2) 
( ), 'R tδ is the probability per unit time that a protein binds to its target in the time 
interval { }', 't t dt+ given that it is located a distance, δ , away from the target at time 0 
(δ  is the small distance from the receptor that the ligand is placed when it disassociates).   
 Combining eqs. 1 and 2, we obtain an integral equation that accounts for the state 
of the ligand as a function of its entire history: 
      ( ) ( ) ( ) ( )
0
,
tdf t
k d f R t f t
dt
τ τ δ τ−
⎡ ⎤⎧ ⎫= − −⎢ ⎥⎨ ⎬⎢ ⎥⎩ ⎭⎣ ⎦∫ .   (3) 
We can analyze eq. 3 first by introducing Laplace-transformed variables:    
  ( ) ( )~
0
stf s dte f t
∞
−= ∫  and ( ) ( )~
0
, ,stR s dte R tδ δ
∞
−= ∫ .                                                                      
By substituting the Laplace transforms into eq. 3 and making use of the convolution 
theorem24, we obtain:  
   ( ) ( ) ( )~ ~(0) , 1sf s f k f s R sδ−− = −⎡ ⎤⎣ ⎦  .     (4) 
Or, upon rearranging and inverting the Laplace transform: 
   ( ) ( )( )
~ 0
1 ,
f
f s
s k R sδ−= + −⎡ ⎤⎣ ⎦
   
   ( ) ( )( )
01
2 1 ,
c i
st
c i
f
f t dse
i s k R sπ δ
+ ∞
−− ∞
= + −⎡ ⎤⎣ ⎦∫ .   (5) 
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Thus, the probability that a protein remains bound can be solved exactly provided that an 
explicit form of ( ),R sδ can be obtained and that the resulting Laplace inversion can be 
computed.   
 A convenient way to obtain ( ),R sδ  as developed previously15 is to compute the 
quantity self-consistently by considering the statistics of first passage processes for an 
individual protein disassociating from its ligand: i.e,      
  ( ) ( ) ( )
0
, ( , ) 1 , ( , )
t
R t F t d R t Fδ θ δ θ τ δ τ δ τ= + − −∫      (6) 
whereθ is a parameter that gives the probability that the protein will bind to its substrate 
given that it is within a distanceδ ; and, ( , ') 'F t dtδ is the probability that a protein first 
reaches the origin, starting from a distance δ  at time 0, in the time interval { }', ' 't t dt+ .  
In the case we study, θ is a linear function of the number of phosphorylations n , 0nθ θ=  
where 0θ is the probability that a ligand binds given that it has been singly 
phosphorylated.  The contribution of the first term in eq. 6 is from the probability that a 
ligand is absorbed the first time it reaches its target.  The contribution of the second term 
is from the probability that the ligand reached the target at time { }, dtτ τ + , was reflected 
(i.e. the ligand did not bind before it diffused away) at that time, and was then later 
absorbed at ( ){ },t t dtτ τ− − + . 
 Again, upon Laplace transforming eq. 6 and the first passage time PDF, i.e. 
( ) ( )~
0
,stF s dte F tδ
∞
−= ∫ , and again, noting the convolution theorem, eq. 6 becomes: 
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  ( ) ( ) ( )~ ~ ~ ~, ( , ) 1 , ( , )R s F s R s F sδ θ δ θ δ δ= + −       
             ( ) ( )
~
~
~
( , ),
1 1 ( , )
F sR s
F s
θ δδ
θ δ
=
− −
.    (7) 
 In the work by Tauber and coworkers15, a similar equation as eq. 7 is used to 
compute ( ),R tδ .  However, in their treatment of the calculation of ( ),R tδ , the 
coefficients θ and 1 θ− in eq. 6 are replaced with ( )( )1 f tθ − and ( )( )1 1 f tθ− − .  In 
their problem, the authors considered rebinding to receptors on a planar surface and the 
probability that a ligand reaches a receptor that contains a ligand that already contains a 
bound ligand need be taken into account.  Our equation for the absorption probability 
does not require the additional ( )1 f t−  factor since we are only considering the 
rebinding of a receptor to a single isolated receptor. 
 For further analysis, the first-passage time distribution function is now required 
and is considered in three dimensions.  Assuming spherical symmetry, the solution to the 
first passage problem can be obtained in the Laplace domain and its derivation is 
contained in the appendix; thus, 
  
~
( ; ) saF a s e
a
τε ε
−⎡ ⎤+ ≈ ⎢ ⎥+⎣ ⎦ .    (8)   
 The distance, δ , is written as aδ ε= +  ( a is the radius of the recognition domain 
and ε is the average distance away from the boundary of the recognition domain that the 
ligand is initially displaced when it rebinds) the variable ( )2a
D
ετ +=  has been 
introduced along with D  being the diffusion constant of the ligand.  τ is the time it takes 
for the ligand to diffuse a distance on the order of the distance to its target.   
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 A further simplification can be made if we observe the system on time scales 
commensurate with the disassociation time; ~ 1/t k−  ,  i.e. t τ>>  (so that s is small). 
~
( ; )F a sε+   becomes: 
   ( ) ( )~ , 1aF a s s O s
a
ε τ τε ⎡ ⎤+ ≈ − +⎣ ⎦+ .  (9)   
This approximation has been shown to be very good in one dimension15 in which 
rebinding is believed to be more prominent.  Therefore, up to order ( )O sτ , we substitute 
eq. 9 into eq. 7 and obtain: 
   ( ) ( )( )
~ 1
1 ,
1 1
s
R a s
γ γ τε θ γ
− +− + ≈ − −     (10) 
where a
a
γ ε= + . 
Inserting this expression into the integrand in eq. 5 yields: 
   
( ) ( )( )
( ) ( )( )
~ 0
1
01
2 1
eff
stc i
eff
c i
f
f s
s k s
e f
f t ds
i s k s
γ γ τ
π γ γ τ
−
+ ∞
− ∞ −
= ⎡ ⎤+ − +⎣ ⎦
= ⎡ ⎤+ − +⎣ ⎦
∫
   (11) 
where, ( )1 1eff
kk θ γ
−
− = − − .   
Monte Carlo simulations 
 To supplement the theory, we also considered Monte Carlo simulations.  
Simulations were performed by considering a collection of random-walkers with a set of 
receptors on a three-dimensional lattice of 100 x 100 x 100 lattice spacings.  Each protein 
(receptor and ligand) occupy one site on the lattice at any given time.  In each Monte 
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Carlo step, with equal probability for a move to be made in any direction, an attempt to 
allow a molecule to diffuse is given by diffP which defines a time sale that then defines a 
diffusion constant; i.e. 2~ /diffP D L  where D is the diffusion constant and L is the length 
of a lattice spacing which is taken to be the diameter of a typical protein or in this case, 
10L nm∼ .  When encountering an immobile receptor at any of its nearest-neighbor 
positions, the substrate can bind with probability
k
b
E
k T
rxnP P e
+⎛ ⎞−⎜ ⎟⎝ ⎠= , so that ~
k
b
E
k Tk e
+⎛ ⎞−⎜ ⎟⎝ ⎠
+ .  
bk T is Boltzman’s thermal energy, kE + is the energy barrier for association when a 
receptor and ligand come into contact.  In this scheme the rebinding probability 
θ behaves as, 0 ~
k
b
E
k Tn eθ θ
+⎛ ⎞−⎜ ⎟⎝ ⎠= .    
 The fraction of bound ligands was computed by sampling at steady-state, as a 
function of θ , kθ +∝ .  Escape probabilities were computed by first allowing a receptor 
to release its ligand at time 0t = ; at a later time, 0t t= , sampling of whether or not the 
ligand is again bound to its target is performed.  0t was chosen to be a time on the order of 
the encounter time for a protein in a eukaryotic cell; 0 1000t mcsteps=   
(1000 ~ 1mcsteps ms  assuming a lattice spacing of 10L nm= and a diffusion constant 
210 /D m sμ= ).  For each value of θ , the statistics determining the escape probability 
were obtained from 100,000 independent trials.   
RESULTS AND DISCUSSION 
Rebinding probabilities   
From eq. 11, the relevant biological quantities can be computed.  First consider 
the absorption probability in the Laplace domain.  A numerical inversion of eq. 11 
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can in principle be accomplished and the subsequent function plotted.  However, 
since such a computation is difficult to accomplish due to numerical instabilities 
resulting from the multi-scale nature of the computation, we considered the 
function in the Laplace domain.  By substituting the results contained in eq. 8 into 
the expression for ( ),R sδ  (eq. 7), we obtain. 
   ( ) ( )
~
,
1 1
s
s
eR s
e
τ
τ
θγδ θ γ
−
−= − −     (12) 
As seen in Fig. 2a, since the first-passage time distribution decays as a stretched 
exponential function in the Laplace domain, rebinding can be significant over 
many time scales.  
Kinetics of disassociation modified by rebinding events—exponential versus 
non-exponential decay giving rise to ‘strong’ and ‘weak’ regimes of 
rebinding 
 In one dimension, for all parameter ranges, rebinding events lead to 
strongly non-exponential kinetics whenever significant rebinding is possible 
(Appendix).  That is, as a result of rebinding, a ligand can remain bound to its 
receptor long after the time scale that characterizes its dissociation.  In three 
dimensions, the effects of rebinding should be less significant since fewer returns 
to the origin occur in higher dimensions and some trajectories never return to the 
origin25.   
 Upon inspection of the Laplace inversion in eq. 12, two kinetic regimes 
are observed that depend on the relative size of the receptor as determined by 
a
a
γ ε= + .  First, if  
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     ( )1 sγ γ τ− <<     (13) 
(e.g. the radius of gyration of the disordered protein is small compared to the 
radius of the region to which it binds to its targeted substrate, 0ε ≈   and ~ 1γ ), 
then the overall kinetics of ligand disassociation that are modified as a result of 
rebinding events behave in a similar fashion to that of the one-dimensional case15 
as shown in the appendix.  This can be seen by taking the 0ε →  (i.e. 1γ → ) 
limit of eq. 11 in which case,        
    ( ) ( ) ( )0 tf t f e erfc tκ κ→           (14)    
where, 1κ − is a time scale that behaves as
2
2
4k ακ θ
−→  as 1γ →  (appendix). 
 One the other hand, for γ significantly less than one, ( )1 sγ γ τ− >> , 
since τ  is a microscopic time scale, an exponential decay is observed:   
     ( ) dk tf t e−∼    (15) 
where ( )( )
1
1 1d
k
k
γ
γ θ
− −= − −⎡ ⎤⎣ ⎦
. 
 In Fig. 2b, plots of the decay of the probability ( )f t are shown for three 
cases. In the first case, no rebinding binding ( 0θ = ) is considered 
and ( )f t behaves according to: ( ) ( )0 k tf t f e −−= .  In the second case, strong 
rebinding is considered ( 1γ → ) so that ( )f t takes on highly non-exponential 
behavior; i.e.  ( ) ( ) ( )0 tf t f e erfc tκ κ= .   Finally, in the third case, weak 
rebinding is considered ( 1γ < ) so that ( )f t takes the form: ( ) ( )0 dk tf t f e−= .  
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The parameter values used are given in the figure caption.  As shown in the plot, 
the two regimes of rebinding lead to dramatically different consequences.  When 
the ligand begins significantly far away from its target leading to the weak ( 1γ < ) 
rebinding regime, rebinding serves simply to decrease the off rate ( dk k−< ).  In 
contrast, when the ligand begins close to its target (or the target is very large in 
comparison to the ligand), 1γ →  and the shape of the disassociation curve 
changes dramatically resulting in nonexponential disassociation kinetics.  The 
presence of a distribution with a fat tail (i.e.  ( )1/ 2~ ; 1/t t κ− >> ) is observed; this 
signifies that the release of the ligand is distributed over many time scales – the 
ligand becomes trapped by the receptor for long times.  
The fraction of bound ligands can be greatly influenced by rebinding 
 With the formulas obtained in eqs. 14 and 15, ( )0,f tθ , the probability that 
a ligand remains bound as a function of θ , can be studied at different time points, 
0t .  Shown in Figs. 3a and 3b, the behavior of these functions is plotted.  For the 
strong rebinding ( 1γ → ) case in fig 3a, it can be seen that the fraction of bound 
ligands is strongly influenced by rebinding over a broad range of time scales (i.e. 
0.001s – 1000s).  On the other hand, for weak rebinding, the fraction of bound 
ligands is only strongly influenced by rebinding on a time scale, τ−  
commensurate with the intrinsic off-rate (i.e.  1
k
τ−
−
∼ ).  Such behavior is a direct 
consequence of the non-exponential vs. exponential shapes of the decay curves.  It 
is also noted that fitting each curve to a Hill function 
50%
H
H HK
θ
θ+ by nonlinear 
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regression, gives a value of 1H ∼ for all curves indicating a ‘Michaelian’ dose 
response2.     
Escape probabilities and the effects of rebinding on dose response curves 
 The escape probability can be computed within this theory from a consideration 
of the fraction of bound ligands ( )0,f tθ .  ( )01 ,f tθ− gives the probability that a ligand is 
not bound to its target at time 0t  (i.e. the probability that the ligand has “escaped”).  As 
seen in the plots in Figs. 3a and 3b, for large enough values of θ , long after the 
disassociation from the first order decay process, ligands can be trapped by their 
receptors.   
 In the weak rebinding regime, the escape probability has the functional form: 
( ) [ ]0 01 , 1 exp
af t t
b c
θ θ
⎛ ⎞− ≈ − −⎜ ⎟+⎝ ⎠
 as can be seen upon rearranging eq.  15.  On the other 
hand, in the strong rebinding regime (eq. 14), the escape probability behaves as: 
( ) ( )200 01 , 1 atf t e erfc a tθθ θ−− ≈ − .  For typical parameter values, these functions decay 
at rates commensurate with the rates of an exponential process characterized by a single 
time scale as seen in Figs. 3a and 3b.   
 Alternatively, Monte Carlo simulations26 can be used to compute the escape 
probabilities numerically.  Plots of the escape probabilities are shown in Fig. 4a; as 
indicated on the inset of the plot, the data obtained from the Monte Carlo simulations are 
shown to fit well to an exponential decay function with a single parameter i.e. 
( )0, kf t e θθ −∼ .  The fraction of receptors bound as a function of θ is also computed 
from the computer simulations and plotted in Fig. 4b.  Different values of receptor 
density are considered.  For each curve, as exemplified on in the inset of Fig. 4b, a fit to a 
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Hill function gives a Hill coefficient of near unity.  The plots in Fig. 4b. are consistent 
with those obtained from the theory and plotted in Fig. 3a.   
 While the curves in Figs. 3a,b and 4b show that the Hill coefficient is near unity, 
thresholding effects in the dose response curves may appear when rebinding is significant.  
This thresholding effect that is observed in Figs. 3a, b, and 4b is defined as a different 
value of θ needed to reach a given value of ( )0,f tθ .  These results are thus similar to the 
observations that have been previously reported4 that considered the case of multiple 
phosphorylation steps that occur in an ordered, distributive manner.  This result is 
therefore expected to become more prominent upon incorporation of the possibility of 
rebinding.    
 Finally, we considered how the fraction or probability that a ligand remains bound 
vary as a function for the number of phosphorylations, n for different values of 0θ  (recall: 
0nθ θ= ).  Four cases are shown: the strong rebinding ( 1γ → ) case at long (100s ) and 
short (10s ) times (Figs. 5a,b), and the weak rebinding ( 1γ < ) at long (5s )and short (1s ) 
times (Figs. 5c,d).  As seen, graded responses are observed in each of these cases.  
Perhaps interesting to note is the non-uniformity of these dose response curves; some 
appear near linear while others have a nonlinear, hyperbolic shape.  This effects results 
from a rescaling of 0θ .  For different values of 0θ , the response to changing values of 
n is different.       
Comparison to previous theoretical work on ligand rebinding and 
multisite phosphorylation 
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 Previous theoretical work has also studied the effects of multisite phosphorylation.  
In a prior study10, a theoretical model predicted an exponential decay in the escape 
probability as a function of the number of phosphorylations.  This exponential decay was 
predicted to be sufficient to give a highly cooperative dose response curve (the addition 
of a single independent binding site results in a large increase in the fraction of ligands 
bound to their receptors).  The model that was developed consists of a ligand existing in 
one of three states: bound to the receptor (B), in a region proximal to the receptor (P), and 
a region far away from the receptor (F).  Transitions between these states are considered 
that result in the following kinetic scheme with kinetic constants, , , ,on off esc capk k k k ;    
    off esc
on cap
k k
k k
B P FZZZX ZZZXYZZZ YZZZ . 
  The fraction of bound ligands is taken to be the proportion of ligands in the bound and 
proximal states (i.e. B
tot
B Pf
L
+= where B is the number of ligands in the bound state, P is 
the number of ligands in the proximal state, and totL is the total number of ligands.).  
Using mass action kinetics, an expression for Bf as a function of the kinetic constants and  
number of available receptors fR  can be computed
10:   
     1
1B
f κ= +     (16) 
where,  
     
1
1esc onf
cap off
k kR
k k
κ
−⎡ ⎤⎛ ⎞= +⎢ ⎥⎜ ⎟⎜ ⎟⎢ ⎥⎝ ⎠⎣ ⎦
.  (17)   
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offk is an off rate for dissociation of a bound ligand and onk is an on rate that is taken to be 
proportional to the number of phosphorylations ( onk n∝ ).  esck is computed from first 
passage time statistics and is shown to decay exponentially anesck e
−∝  as a function of the 
number of phosphorylations n .  It is also assumed that capk is a diffusion limited rate 
constant17 and is taken to be independent of n 10; that is, ( )04cap l r Ak R D D Nπ= + where 
0R is the radius of the receptor, lD and rD are diffusion constants for the ligand and 
receptor respectively, and AN is Avogadro’s number.     
 From the expression, it is clear that, for some parameter values, a highly 
cooperative response2 can obtained when esck decays exponentially for increasing n while 
keeping capk fixed.  However, in the framework of the model, it is not clear why capk (a 
rate constant of diffusion limited capture for ligands to enter the proximal region near the 
receptor) is independent of n  or esck .  If more ligands are immediately rebinding to their 
receptors and as a result esck decreases, then fewer ligands are available to diffuse into the 
proximal region denoted by the F P→ transition.  capk , it seems, should decrease 
accordingly.                
 Consistent with this model, the theory and Monte Carlo simulations both predict a 
fast (and nearly exponential) decrease in the probability of escape for a ligand as a 
function of the number of phosphorylations as seen in Fig. 4a. This exponential decrease 
in the probability of escape of a newly disassociated ligand, however, appears insufficient 
to produce a highly cooperative response due to rebinding (Fig. 4b).  The discrepancy 
between these two findings appears to lie in the assumption of a constant value of 
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capk that was used.  The Monte Carlo simulations show that the allovalent model predicts 
a Michaelian2 (i.e. Hill coefficient of unity) response.  This result is perhaps not 
surprising since there is no cooperativity introduced into the model.  The effect of 
rebinding, in itself, appears insufficient to give a cooperative response.  However, despite 
this apparent lack of cooperativity, differential rebinding effects (with respect to changes 
in the number of binding sites) can be very significant as has been emphasized 
throughout this work.               
Summary 
 We first reformulated the problem of the rebinding of a protein with multiple 
independent phosphorylation sites, to its target in the context of a self consistent integral 
equation theory14,15, to study the effects of one dimensional ligand rebinding to a surface 
containing antibody receptors.  Within this formalism, we solved the rebinding problem 
of a single ligand to an isolated receptor in three dimensions in two limits that depend on 
the relative sizes of the receptor and ligand.  We find two qualitatively distinct regimes of 
rebinding kinetics whose crossover depends mainly on the size of the substrate and its 
target.  In one regime (i.e. when there is strong rebinding), the kinetics of ligand 
disassociation takes on a similar functional form to that of the one-dimensional case—
this results resulting in a slow decay of bound substrates characterized by non-
exponential kinetics and a power law tail.  Alternatively, in the other regime (i.e. when 
there is weak rebinding), the behavior of the kinetics of disassociation exhibits an 
exponential form and is thus characterized by a single rate constant – rebinding gives 
simply a slower time constant signifying a lesser influence on rebinding.  The model 
predicts that the relative size of the ligand (that determines the rebinding regime) may 
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play a key role in determining the functional role of multisite phosphorylations.  It may 
be interesting to study how the different regimes of rebinding, that are predicted in this 
model, relate to other biological processes that require ligand rebinding at different length 
and time scales, such as autocrine signaling27.    
 We then used the results obtained to compute rebinding probabilities.  We 
showed that, in some instances, rebinding can occur over many time scales and 
contribute significantly to the total bound fraction of ligands.  Furthermore within 
this model, an increase in the number of independently acting phosphorylation 
sites leads to a near exponential decrease in the probability that a ligand escapes 
from its target (i.e. it diffuses a large distance without being captured by its target).  
The model also predicts a graded response2 and yields a Hill coefficient of near 
unity for all parameter values.  Thus, statistically independent contributions to the 
association rate of the ligand in the form of additional binding sites and their 
additive effect on the association rate (while potentially having a great impact on 
the binding kinetics) does not appear to in itself yield a highly cooperative 
response.  These additional binding sites can, however, influence the shape of the 
dose response in a nonlinear manner.   
 Previous theoretical work10 has also studied the effects of multisite 
phosphorylation on substrate rebinding.  This model also predicts an exponential 
decay in the escape probability as a function of the number of phosphorylations.  
This effect then gives rise to a highly cooperative dose response curve (the 
addition of a single independent binding site can result in a large increase in the 
fraction of ligands bound to their receptors).  However, a high degree of 
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cooperativity is not observed in both our theoretical treatment and Monte Carlo 
simulations.   
 Although rebinding may not, in itself, produce a ‘switch-like’ (i.e. highly 
cooperative) dose response curve2 in the fraction of ligands bound, it is 
nevertheless interesting to speculate on the ways in which the rebinding of a 
substrate to its receptor may affect myriad cellular processes.  For instance, by 
controlling the probability of rebinding in the form of changing the number of 
phosphorylations on an enzyme, the degree of processive vs. distributive 
enzymatic modifications2,28 that comprise a multi-step pathway could be 
controlled.  It is also possible that the parameterγ in our model that is determined 
by the relative size of the receptor and ligand and other structural features of the 
protein-protein interaction would be a key determinant in the number of 
processive versus distributive phosphorylation events28.       
  Many mechanisms have been proposed (and some tested) that can 
account for switch-like dose responses involving proteins with multisite 
phosphorylations15,22,29.  In the language of our model, such effects would result 
in θ having a complex, nonlinear relationship with n and 0θ .  It may be 
interesting to explore how these mechanisms containing phenomena such as 
decoy phosphorylation, entropically driven binding, or electrostatics may couple 
to the effects of ligand rebinding as studied here. 
 Finally, the explicit geometry of the binding sites was not considered in 
this work.  Other theoretical works19,30 have shown that these effects can be 
important in polyvalent ligand binding.  In future work, it may be interesting to 
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investigate these geometrical aspects of multisite phosphorylation and ligand 
rebinding.  Such a study might be accomplished, for example, by borrowing ideas 
from polymer physics31, and considering the dynamics of a flexible polyvalent 
chain and its interaction with a substrate.     
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Appendix 
First passage time statistics and rebinding in three dimensions 
The rebinding problem is now considered in three dimensions.  Assuming spherical 
symmetry, the solution to the first-passage problem can be obtained in terms of modified 
Bessel functions.  We introduce the survival probability  
    ( ) ( )
0
( ; ) ' , ' = 1 ' , '
t
t
t dt F t dt F tη η η
∞
Φ = −∫ ∫   (A1) 
so that, 
    ( ),( ; ) d tF t
dt
ηη Φ= − .     (A2) 
In the Laplace domain:  
    
~
0
( ; ) ( ; )sts dte tη η
∞
−Φ = Φ∫ ,    (A3) 
The first passage time PDF can be written as follows: 
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   ( ) ( ) ( )~ ~ ~( ; ) ,0 , 1 ,F s s s s sη η η η= Φ − Φ = − Φ    (A4) 
where, ( ),0 1ηΦ = (the survival probability at time zero is defined as 1).  The survival 
probability can be obtained by solving a backwards Kolmogorov equation25,32 that has the 
form of a diffusion equation 
     ( ) ( )2, ,t D t
t
δ δ∂Φ = ∇ Φ∂ , 
or, in the Laplace domain:  
        ( ) ( )~ ~2 , , 1D s s sδ δ∇ Φ = Φ −  ,             (A5) 
(from hereon, length is scaled with respect to a diffusion length scale; 
;s a
D
η δ δ ε= = + ) with absorbing boundary condition, 
     ( ), 0a sηΦ =         (A6) 
where a
sa
D
η =  and a  is the radius of the sphere containing the targeted substrate.  
For the other boundary condition, far away from the target at a distance, 0η , ( ; )tηΦ is 
unity; i.e. 
       
~
0
1( ; )s
s
η ηΦ → = .        (A7) 
In spherical coordinates, eq. A5 becomes:   
   
~ ~
2 ~
2
( ; ) 2 ( ; ) 1( ; ) 0d s d s s
d d s
η η ηη η η
Φ Φ+ −Φ + =    (A8) 
and has the general solution: 
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   ( ) ( )~ 1/ 2 1/ 21/ 2 1/ 21( ; ) I Is A Bs
η ηη η η
−Φ = + +   
      ( ) ( )1 2 cosh sinhA B
s
η η
π η η
⎡ ⎤= + +⎢ ⎥⎣ ⎦
.  (A9) 
where ( )vI x is a modified Bessel function of order v . 
The solution for 
~
( ; )sηΦ  that satisfies the boundary conditions in eqs. A6 and A7 gives 
the coefficients A and B: 
   ( )( )0 02
a
a
sinh
A
s sinh
ηπ η
η η
⎛ ⎞= ⎜ ⎟ −⎝ ⎠  
 and  
   ( )( )0 02
a
a
cosh
B
s sinh
ηπ η
η η
⎛ ⎞= − ⎜ ⎟ −⎝ ⎠ . 
Substituting the coefficients into eq. A9 and making use of the appropriate trigonometric 
identities gives:    
   ( )( )
~
0
0
1( ; ) 1 a
a
sinh
s
s sinh
η η ηη η η η
⎡ ⎤−Φ = −⎢ ⎥−⎣ ⎦
    (A10)  
Now we assume that the length of the total system (i.e. the cell) is much larger than the 
length of a single protein ( 0 aη η>> ); so that ( ) ( )0 0asinh sinhη η η− ≈ and 
( )0 1atanh η η− ≈ .  Upon substituting these relations and performing some algebraic 
manipulations, we obtain: 
   ( ) ( ){ }~ 1( ; ) 1 as sinh cosh
s
ηη η ηη
⎡ ⎤Φ ≈ − −⎢ ⎥⎣ ⎦  
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    1 1 ae
s
ηη
η
−⎡ ⎤≈ +⎢ ⎥⎣ ⎦
    (A11) 
 Substituting eq. A11 into eq. A4 gives an expression for the first passage time, 
~
( ; )F sη : 
    
~
( ; ) saF a s e
a
τε ε
−⎡ ⎤+ ≈ ⎢ ⎥+⎣ ⎦     (A12) 
where the distance δ  is written as aδ ε= +  and the variable ( )
2a
D
ετ +=  has been 
introduced.  As in a prior study15, a further simplification can be made if we observe the 
system on time scales commensurate with signaling times (times over which signals are 
propagated); 1~t
k−
 ,  i.e. t τ>>  (so that s is small); then ~ ( ; )F a sε+  becomes 
  ( ) ( )~ , 1aF a s s O s
a
ε τ τε ⎡ ⎤+ ≈ − +⎣ ⎦+ .     (A13) 
Therefore, up to order ( )O sτ , we substitute eq. A13 into eq. 7 and obtain: 
   ( ) ( )( )
~ 1
1 ,
1 1
s
R a s
γ γ τε θ γ
− +− + ≈ − −    (A14) 
where a
a
γ ε= + . 
First passage time statistics and rebinding in one dimension 
Although eq. 9 in 1d is exact,
~
( , )F sδ , however, often has a complicated form. Such a 
complication can make the Laplace inversion very difficult. For instance in the 
continuum limit in one dimension25:    
   ( )
2 / 4
1/ 2( ; ) 4
DteF t
tDt
δδδ π
−
=      (B1) 
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which has the Laplace transform: ( ; ) sF s e αδ −=  -- α  is the microscopic time scale that 
it takes a protein with diffusion constant D to diffuse a tiny amount, δ ; 
2
4D
δα =  .  
Subsequently, eq. 11 can be substituted into eq. 9 to obtain: 
    ( ) ( )
2~
2
,
1 1
s
s
eR s
e
α
α
θδ θ
−
−= − −    (B2) 
Despite this complication, additional simplifications can be made if we consider an 
observable time scale of signal transduction, ~ (1/ )sig kτ − , that is much longer than the 
microscopic diffusion time ( sigα τ<< ).  In this case: ( ; ) 1 ( )sF s e s O sαδ α α−= ≈ − + .  
So that upon substituting into eq. B2, we obtain: 
   2( ; ) 1 sR s αδ θ≈ − .     (B3) 
As in a previous study15, substituting eq. B3 into eq. 5 gives: 
   ( ) ( )( )
~ 0
2
f
f s
s k sθ δ−
= + .    (B4) 
eq. B4 can be inverted33:  
   ( ) ( ) ( )0 tf t f e erfc tκ κ=     (B5) 
where 1/κ  is a single characteristic time-scale (
2
2
4k ακ θ
−= ) .   
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Figure 1.)  How biological responses might be shaped by allovalency, multisite 
phosphorylation, and ligand rebinding. 
A schematic for a ligand, with multiple equivalent binding sites, potentially rebinding to 
its enzyme.  Once the ligand unbinds from its target, two possible outcomes are available: 
1.) escape from its binding partner (i.e. diffuse a distance far away from the receptor) and 
2.) immediate rebinding to its receptor.  A biological response can then be initiated if the 
protein is bound sufficiently long.  The outcome is expected to depend on the number of 
sites (in the form of phosphorylations of the protein) that are available.  Circles depict 
different potential binding sites that arise from phosphorylations.   
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Figure 2.) Strong ligand rebinding can be significant over many time scales. 
a.) Plots of the absorption probability in the Laplace domain, ( ; )R sδ , with units chosen 
so that the microscopic diffusion time scale τ  is unity, 1τ = ; ( ( )2a
D
ετ += ), are shown 
on a log-log plot. The strong rebinding limit is considered, 1γ → , for convenience.  
1( ; ) ( ; )
2
c i
st
c i
R t dsR s e
i
δ δπ
+ ∞
− ∞
= ∫ is the probability that a ligand absorbs to its target a distance 
δ away at time t .  ( ; )R tδ contains all known information on the statistics of an 
individual ligand’s past history of rebinding attempts.  Plots are generated from the 
expression obtained using eq. B2 .  b.)  Shapes of the dissociation curves in three limits: 
1.) when no binding occurs, 2.) when 1γ →  (strong rebinding), and 3.) when 0 1γ< <  or 
( )O aε ε= + (weak rebinding).  Dashed lines show the behavior of the decay curve in the 
absence of rebinding, 1k− = . Dotted lines give the case when the decay curve for 
rebinding takes the form of the strongly non-exponential one-dimensional case i.e. 1γ = .  
The time constant, κ  (
2
2
4k ακ θ
−= ), in the appendix is taken to be unity 1κ = .  Dash-
dotted lines show the behavior of the decay curve in the instance of weak rebinding limit 
( ( ) 11
2
effk γ− − = ).      
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Figure 3.) Rebinding is influenced by an increase in the number of phosphorylation 
sites. 
( )0,f tθ is plotted for different values of 0t  given on the legend: the two regimes a.)  
strong rebinding, 1γ →  and b.)  weak rebinding regime, e.g. 0.9γ = ; for both instances, 
610 sτ −= , 11k s−− = . ( )0,f tθ gives the probability that a ligand remains bound to its 
target as a function of the number of phosphorylation sites, θ , and at a given time 0t .  
When the time 0t  is commensurate with or greater than the intrinsic time constant 
1
k−
, i.e.   
0
1t
k−
> , the positive contribution to the function, ( )0,f tθ is mostly due to rebinding.    
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Figure 4.) Monte Carlo simulations suggest that an exponential decrease in the 
escape probability for an increasing number of phosphorylation sites can be 
insufficient to produce a switch-like dose response. 
Plots of simulation data from Monte Carlo simulations are shown.  a.) The escape 
probability, Pesc  (defined in the methods section), as a function of θ ( ~
k
b
E
k Teθ
+⎛ ⎞−⎜ ⎟⎝ ⎠ , 
0nθ θ= ) is given.  Three different values of the effective diffusion constant 
diff
eff
rxn
P
D
P
≡ are shown: 1effD = (squares), 10effD = (circles), and 100effD = (crosses).  The 
plot in the inset contains a fit to an exponential function esckPesc e θ−= for the 
1effD = case; 3 110esck mcsteps−= was used in the plot.  b.) The fraction of bound ligand as 
a function of θ is shown.  Four values of a scaled receptor density 
0
ρ
ρ , where 
0 1000 /receptors cellρ = , are considered: 1ρ =  (squares), 2ρ =  (diamonds) 5ρ =  
(circles) 10ρ = (crosses).  The plot in the inset gives a fit to a Hill function, 
50%
H
H HK
θ
θ+  
with H = 1, for the case of 1ρ = .  Error bars from the simulations are on the order of 5% 
of the reported values.   
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Figure 5.) Graded responses are observed for over wide ranges of parameter values. 
Plots of ( )0,f n t  in which 0nθ θ=  are shown for different values of 0θ .  The number of 
phosphorylations, n is plotted along the abscissa.  Strong (a,b) and weak (c,d) rebinding 
limits are considered.  Numbers on the legend indicate the different values of 0θ  that 
were used.  In the strong rebinding cases (a,b), two time points, 0t , are given: a.) 
0 100t s= and b.) 0 1t s= .  In the weak rebinding cases (c,d), the two values of 0t  used 
were: c.) 0 5t s=  and d.) 0 1t s= .  
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Figure 1.)  
a a
δ = a + ε
Biological Response vs. Escape
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